[EN] USE OF IGF-2 RECEPTOR AGONIST LIGANDS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM<br/>[FR] UTILISATION DE LIGANDS AGONISTES DU RÉCEPTEUR DE L'IGF-2 POUR LE TRAITEMENT DU SYNDROME D'ANGELMAN ET DE L'AUTISME
申请人:UNIV NEW YORK
公开号:WO2020033971A1
公开(公告)日:2020-02-13
Provided are methods for treatment of neurodevelopmental disorders, such as Angelman Syndrome and autism comprising administering to an individual a composition comprising an agonist ligand of IGF -2 receptor. The agonist ligand of IGF-2 receptor may be IGF -2, or mannose-6-phosphate or a derivative thereof. Compositions comprising mannose-6-phosphate derivatives are also disclosed.
[EN] USE OF MANNOSE 6 PHOSPHATE AND MODIFICATIONS THEREOF FOR MEMORY ENHANCEMENT AND REDUCING MEMORY IMPAIRMENT<br/>[FR] UTILISATION DE MANNOSE-6-PHOSPHATE ET SES MODIFICATIONS POUR L'AMÉLIORATION DE LA MÉMOIRE ET LA RÉDUCTION DES TROUBLES DE LA MÉMOIRE
申请人:UNIV NEW YORK
公开号:WO2020033972A1
公开(公告)日:2020-02-13
Provided are compositions and methods for memory enhancement, including recovery of memory impairment. The compositions and methods relate to mannose-6-phosphate and derivatives of mannose-6-phosphate. The methods relate to administration of M6P or derivatives thereof to individuals in whom memory enhancement is desired.
Practical palladium-mediated deprotective method of Allyloxycarbonyl in aqueous media
作者:Jean Pierre Geneˆt、Errol Blart、Monique Savignac、Stéphane Lemeune、Sandrine Lemaire-Audoire、Jean-Marc Paris、Jean-Marie Bernard
DOI:10.1016/s0040-4020(01)80771-7
日期:1994.1
esters, carbamates and carbonates by aqueous Pd (O) catalysed allyl transfer to diethylamine in aqueous media employing a water soluble phosphine. The allyl scavenger as well as by product allyl diethylamine are volatile and easily removed in vacuo. In a two phase system an increased selectivity is seen. The method has been successfully used for deprotection of a wide range of secondary amines or base